![logo](/logos/RXST.webp)
RxSight, Inc.
NASDAQ:RXST
52.95 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | RxSight, Inc. |
Symbool | RXST |
Munteenheid | USD |
Prijs | 52.95 |
Beurswaarde | 2,101,204,260 |
Dividendpercentage | 0% |
52-weken bereik | 20.66 - 66.54 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Ronald M. Kurtz M.D. |
Website | https://www.rxsight.com |
An error occurred while fetching data.
Over RxSight, Inc.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)